NSE: Banking and Pharma Names Show Bullish Turns
Three major NSE stocks T SBIN, Biocon, and Cipla T recently saw significant Altra Score jumps, signaling bullish momentum shifts in their respective
- Visit the stock pages: SBIN, BIOCON, CIPLA
- Sector Nifty Bank Sector , which ranks #2 for Relative Strength (Altra Sector score of 59.0 with bullish regime.)
While the broader NSE market currently presents a "Mixed" signal, with its Altra Market score at 48.8, indicating balanced breadth with approximately 50% of stocks above key moving averages, individual stock and sector-level momentum tells a more nuanced story. This mixed market backdrop, which often suggests caution or reduced position sizes, hasn't prevented specific names from showing clear bullish momentum shifts. Three stocks across the Nifty Bank and Nifty Pharma sectors recently demonstrated notable upticks in their Altra Scores, a proprietary 0-100 momentum rating derived from EMA alignment and RSI trends across daily, weekly, and monthly timeframes, where higher scores signal stronger bullish momentum.
SBIN
State Bank of India (SBIN) saw a dramatic shift on July 15, 2026, as its Altra Score surged from 25.8 to 83.9, moving from a "Bearish" to a "Strong Bullish" regime. This significant momentum increase occurred within the Nifty Bank Sector, which itself holds a bullish Altra Sector score of 59.0 and is ranked second among NSE sectors. The Altra Sector score measures sector-wide momentum, also factoring in relative strength against other sectors. Despite this positive individual momentum, the Nifty Bank Sector is currently described as a "Confirmed leader, cooling off," evidenced by a slight negative 4-week relative strength trend of -0.72, though its EMA spread remains healthy at 3.70 and its relative strength RSI is 61.9. SBIN's technical posture supports its new bullish rating, with the stock positioned above its key Exponential Moving Averages (EMAs) and having registered a bullish Weekly EMA Crossover on June 22, 2026. Its daily, weekly, and monthly Relative Strength Index (RSI) readings of 52.11, 51.63, and 59.0, respectively, reflect building positive sentiment without being overextended.
BIOCON
Biocon Ltd. (BIOCON) exhibited an even more striking momentum surge on July 14, 2026. Its Altra Score rocketed from 48.8 ("Neutral") to an exceptional 98.0 ("Strong Bullish"), and currently stands at a robust 85.6, maintaining its "Strong Bullish" status. This move comes within the Nifty Pharma Sector, which is currently the top-ranked sector on the NSE with a highly bullish Altra Sector score of 91.0. Unlike the Nifty Bank Sector, the Nifty Pharma Sector is characterized as a "Confirmed leader, holding steady," with a positive 4-week relative strength trend of +2.96 and a strong relative strength RSI of 71.6, alongside a healthy EMA spread of 5.63. BIOCON's price action is firmly above its key EMAs, and it underwent a bullish Weekly EMA Crossover earlier on May 15, 2026. Its RSI readings across daily (59.43), weekly (64.08), and monthly (61.65) timeframes all signal strong and sustained positive momentum.
CIPLA
Cipla Ltd. (CIPLA), another significant player in the Nifty Pharma Sector, also showed a positive shift on July 14, 2026. Its Altra Score climbed from 48.4 ("Neutral") to 69.9 ("Bullish"), and currently holds at 62.2, maintaining a "Bullish" momentum. As with Biocon, Cipla benefits from the strong tailwinds of the Nifty Pharma Sector, which is ranked #1 with an Altra Sector score of 91.0 and is firmly a "Confirmed leader, holding steady." Cipla's price is trading above its key EMAs, and it experienced a bullish Weekly EMA Crossover on June 22, 2026. Its daily and weekly RSI readings of 53.43 and 56.21 indicate favorable short-to-medium term strength, though its monthly RSI of 49.17 suggests longer-term consolidation before its recent move. Together, Biocon and Cipla highlight the robust momentum currently seen within the leading Nifty Pharma Sector, even as the broader market shows mixed signals.
These cross-sector momentum shifts in SBIN, Biocon, and Cipla underscore the utility of multi-timeframe analysis in identifying high-probability setups, even when the overall market environment suggests caution. While the Altra Market score indicates balanced market breadth, these individual stock and sector-level advancements demonstrate where pockets of strength are emerging.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.